Cue Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	51.36	54.88	67.24	77.59	47.01	21.86	63.58	15.04	6.5
Short-Term Investments	0	24.68	0	10	15.12	18.41	0	0.05	0.05
Cash & Cash Equivalents	51.36	79.56	67.24	87.59	62.13	40.28	63.58	15.09	6.55
Cash Growth	-35.45%	18.31%	-23.23%	40.97%	54.27%	-36.66%	321.28%	130.29%	-
Receivables	1.7	0.06	3.14	1.42	0.75	0	0	0	0
Other Current Assets	-1.6	-2.43	-1.92	-1.48	-1.86	0.33	1.48	0.05	-0.05
Total Current Assets	51.45	77.19	68.47	87.53	61.02	40.61	65.07	15.14	6.51
Property, Plant & Equipment	7.12	10.7	11.92	8.88	7.18	2.78	1.69	1.02	0.71
Long-Term Investments	0	0	0	0	0	0.15	0	0	0
Other Long-Term Assets	2.96	3.39	3.01	3.12	3.4	1.82	0.2	0.12	0.1
Total Long-Term Assets	10.08	14.1	14.93	12.01	10.58	4.75	1.89	1.14	0.81
Total Assets	61.53	91.28	83.4	99.53	71.61	45.36	66.95	16.28	7.31
Accounts Payable	3.5	2.73	2.59	2.07	0.88	2.04	1.66	0.55	0.18
Current Debt	7.33	5.26	4.93	4.78	4.45	0	0	0	0
Other Current Liabilities	6.25	3.55	5.27	9.47	6.32	4.18	3.69	0.52	0.16
Total Current Liabilities	17.08	11.55	12.79	16.32	11.66	6.22	5.35	1.07	0.34
Long-Term Debt	7.36	14.05	5.12	2.37	1.35	0	0	0	0
Other Long-Term Liabilities	0	0	0	1.94	4.02	5.17	0	0.04	0.03
Total Long-Term Liabilities	7.36	14.05	5.12	4.31	5.37	5.17	0	0.04	0.03
Total Liabilities	24.45	25.6	17.91	20.62	17.02	11.39	5.35	1.1	0.38
Total Debt	14.7	19.32	10.05	7.15	5.8	0	-	-	-
Debt Growth	-23.92%	92.14%	40.67%	23.30%	-	-	-	-	-
Retained Earnings	-301.19	-250.46	-197.45	-153.29	-108.5	-71.8	-32.82	-9.59	-1.93
Comprehensive Income	0	-0.1	0	0.01	-0.01	-0.01	0	0	0
Shareholders' Equity	37.09	65.68	65.49	78.91	54.58	33.97	61.61	15.17	6.94
Net Cash / Debt	36.66	60.24	57.19	80.44	56.34	40.28	63.58	15.09	6.55
Net Cash / Debt Growth	-39.14%	5.33%	-28.91%	42.79%	39.88%	-36.66%	321.28%	130.29%	-
Net Cash Per Share	0.80	1.69	1.83	2.80	2.56	2.00	5.92	2.03	1.16
Working Capital	34.37	65.64	55.68	71.21	49.37	34.39	59.72	14.07	6.16
Book Value Per Share	0.81	1.84	2.09	2.75	2.48	1.69	5.74	2.04	1.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).